How should an infected human bite be managed in a pediatric patient?

Treatment for Infected Human Bite in Pediatrics

For an infected human bite in a pediatric patient, treat with oral amoxicillin-clavulanate 875/125 mg twice daily (dose-adjusted for weight in children), ensure thorough wound irrigation and debridement, and update tetanus prophylaxis. 1

Antibiotic Selection

The IDSA guidelines strongly recommend amoxicillin-clavulanate as first-line therapy for infected human bites 1. This choice is critical because human bite wounds harbor a complex polymicrobial flora including:

• Aerobic organisms: Streptococci, S. aureus, and Eikenella corrodens
• Anaerobic organisms: Fusobacterium, Peptostreptococcus, Prevotella, and Porphyromonas species

A crucial pitfall: Eikenella corrodens is resistant to first-generation cephalosporins, macrolides, clindamycin, and aminoglycosides, making these agents inappropriate choices 1.

Alternative Regimens for Penicillin Allergy

If the child has a β-lactam hypersensitivity:

• Fluoroquinolone plus metronidazole (ciprofloxacin or levofloxacin + metronidazole), OR
• Moxifloxacin as monotherapy 1

Note: Fluoroquinolones have age-related restrictions in pediatrics and should be reserved for situations where benefits outweigh risks.

For intravenous therapy in severe infections:

• Ampicillin-sulbactam 1.5-3.0 g every 6 hours
• Ertapenem (dose-adjusted for pediatrics) 1

Wound Management Strategy

Do NOT perform primary closure on infected human bite wounds 1. The evidence strongly supports this approach:

• A 2025 retrospective study of 660 pediatric human bite cases demonstrated that delayed closure had significantly lower infection rates compared to primary closure (12.6% vs 29.0%, P < 0.001) 2
• Primary closure was an independent predictor of wound infection (RR 4.375) 2
• Delayed closure achieved both low infection rates AND optimal wound healing (76.4% optimal healing rate) 2

Wound Care Algorithm

1. Copious irrigation with normal saline
2. Careful debridement of devitalized tissue
3. Leave wound open initially for infected bites
4. Consider delayed closure after 3-5 days if infection resolves
5. Exception: Facial wounds may be approximated (not tightly closed) after thorough irrigation and with preemptive antibiotics, given cosmetic concerns 1

Risk Factors for Infection

Be particularly vigilant with:

• Advanced age (older children have higher infection risk, RR 1.195 per year) 2
• Delayed presentation (each additional hour increases infection risk, RR 1.029) 2
• Hand injuries (higher infection rates than other locations)
• Immunocompromised patients

Tetanus Prophylaxis

Administer tetanus toxoid if >5 years since last dose for contaminated wounds, or >10 years for clean wounds 1. In pediatric patients who haven't completed the primary series, ensure completion. Tdap is preferred over Td if not previously given 1.

Duration and Follow-up

• Treat for 7-10 days based on clinical response 1
• Mandatory follow-up is essential, as seemingly minor infections can worsen 3
• Monitor for signs of deeper infection, abscess formation, or systemic involvement

Common Pitfalls to Avoid

1. Using first-generation cephalosporins - these miss Eikenella corrodens 1
2. Primary closure of infected wounds - quadruples infection risk 2
3. Inadequate irrigation and debridement - wound care is as important as antibiotics
4. Forgetting tetanus status - human bites are contaminated wounds requiring prophylaxis 1
5. Inadequate follow-up - infections can develop or worsen after initial treatment 3

Human bites in children most commonly occur on the head/neck (81.4% of cases) and are predominantly seen in males (85.2%) 2. The overall infection rate is approximately 16.8% when managed appropriately 2, though this can reach 50% with suboptimal management 4.